• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy.

作者信息

Elias Dominique, Youssef Omar, Sideris Lucas, Dromain Clarisse, Baton Olivier, Boige Valérie, Ducreux Michel

机构信息

Department of Surgical Oncology, Gustave Roussy Institute, Villejuif, France.

出版信息

J Surg Oncol. 2004 Apr 1;86(1):4-9. doi: 10.1002/jso.20039.

DOI:10.1002/jso.20039
PMID:15048673
Abstract

BACKGROUND

A dramatic response to chemotherapy in some patients with multiple bilateral and initially unresectable liver metastases (LM) from colorectal cancer sometimes leads to their disappearance from imaging studies. Our study was aimed at assessing the evolution of these metastases when they were also not found during liver surgery.

PATIENTS

Among 104 hepatectomized patients for colorectal LM in 4 years, 15 patients were retrospectively eligible. Eligibility criteria were: initially unresectable LM; a dramatic response to chemotherapy; and the complete disappearance of at least one LM on imaging studies (ultrasonography (US), computed tomography, and magnetic resonance) during more than 3 months. In four patients (27%), the disappeared LM could be found and treated at laparotomy. The main selection criterion for the 11 studied patients of this series was the impossibility of finding and treating the disappeared LM sited in the remaining liver after hepatectomy, resulting in "missing LM."

RESULTS

After a median follow-up of 31 months (range: 18-55) for the series, eight patients among the eleven (73%) did not present any recurrence of the missing LM. The median follow-up was 31.3 months for these eight patients. The three recurrences occurred respectively at 5, 5, and 8 months after surgery.

CONCLUSIONS

The disappearance of LM after chemotherapy on high-quality imaging studies and after intra-operative liver exploration resulted in their definitive cure in approximately 70% of cases. The current dogma stipulating an obligatory resection of the initially affected part of the liver is no longer acceptable.

摘要

相似文献

1
Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy.
J Surg Oncol. 2004 Apr 1;86(1):4-9. doi: 10.1002/jso.20039.
2
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.多中心试验 OPTILIV 中,肝动脉灌注联合化疗和全身西妥昔单抗治疗结直肠癌肝转移转化为切除术。
Ann Oncol. 2016 Feb;27(2):267-74. doi: 10.1093/annonc/mdv548. Epub 2015 Nov 16.
3
[Hepatectomy for colorectal liver metastases after neoadjuvant chemotherapy].新辅助化疗后结直肠癌肝转移灶的肝切除术
Bull Cancer. 2011 Jan;98(1):11-8. doi: 10.1684/bdc.2010.1284.
4
A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.一项在一线治疗初始不可切除或不能完全切除肝转移的结直肠癌患者中三种强化化疗方案的随机 II 期试验。METHEP 试验。
Ann Surg Oncol. 2013 Dec;20(13):4289-97. doi: 10.1245/s10434-013-3217-x. Epub 2013 Aug 17.
5
Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis.肝切除术治疗初始不可切除结直肠肝转移术后早期复发的预测因素。
J Gastrointest Surg. 2013 May;17(5):939-48. doi: 10.1007/s11605-013-2162-0. Epub 2013 Feb 12.
6
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.西妥昔单抗新辅助化疗后结直肠癌肝转移的肿瘤反应和二次可切除性:CELIM 随机 2 期试验。
Lancet Oncol. 2010 Jan;11(1):38-47. doi: 10.1016/S1470-2045(09)70330-4. Epub 2009 Nov 26.
7
Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases.术前化疗完全病理缓解对结直肠癌肝转移治疗的重要性。
Ann Surg. 2009 Dec;250(6):935-42. doi: 10.1097/sla.0b013e3181b0c6e4.
8
Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.在进行右侧肝脏大部切除以治疗双侧结直肠癌转移之前,同时进行经皮右门静脉栓塞和左肝肿瘤射频消融。
Hepatogastroenterology. 2004 Nov-Dec;51(60):1788-91.
9
Timing of two-stage liver resection during chemotherapy for otherwise unresectable colorectal metastases.化疗期间不可切除结直肠转移瘤的两阶段肝切除术时机。
World J Surg. 2012 Aug;36(8):1832-41. doi: 10.1007/s00268-012-1578-0.
10
Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?结直肠癌伴腹膜转移及肝同步转移患者:哪些人能从完全肿瘤细胞减灭术中获益?
Int J Surg. 2016 Jan;25:98-105. doi: 10.1016/j.ijsu.2015.11.025. Epub 2015 Dec 1.

引用本文的文献

1
The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery.结直肠癌肝转移灶消失的挑战:权衡肿瘤生物学与肝脏手术临床后果之间的考量
Clin Exp Metastasis. 2025 Jul 12;42(4):39. doi: 10.1007/s10585-025-10357-y.
2
A Systematic Review of Disappearing Colorectal Liver Metastases: Resection or No Resection?结直肠癌肝转移灶消失:切除还是不切除?一项系统综述
J Clin Med. 2025 Feb 10;14(4):1147. doi: 10.3390/jcm14041147.
3
Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.
探索结直肠癌肝转移瘤在一线化疗期间消失或残留小病灶在肝胆对比增强磁共振成像和扩散加权磁共振成像上的表现
Cancers (Basel). 2023 Apr 8;15(8):2200. doi: 10.3390/cancers15082200.
4
Missing colorectal liver metastases: the surgical challenge.结直肠肝转移瘤的外科治疗挑战
Langenbecks Arch Surg. 2021 Nov;406(7):2163-2175. doi: 10.1007/s00423-021-02297-4. Epub 2021 Sep 30.
5
Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review.消失的结直肠癌肝转移灶的影像学检查及其准确性:一项系统评价
World J Surg Oncol. 2020 Oct 8;18(1):264. doi: 10.1186/s12957-020-02037-w.
6
Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases.评价一种使用术前标记物放置策略以避免肝转移灶遗漏的方法。
BJS Open. 2019 Feb 22;3(3):344-353. doi: 10.1002/bjs5.50140. eCollection 2019 Jun.
7
The impact of intraoperative ultrasonography on the management of disappearing colorectal liver metastases.术中超声检查对消失性结直肠癌肝转移瘤管理的影响
Hepat Oncol. 2015 Oct;2(4):325-328. doi: 10.2217/hep.15.29. Epub 2015 Nov 6.
8
Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?经钆塞酸二钠增强肝脏磁共振成像(MRI)和扩散加权成像检查,化疗后消失或残留的微小(≤5毫米)结直肠癌肝转移灶:是否需要局部治疗?
Eur Radiol. 2017 Jul;27(7):3088-3096. doi: 10.1007/s00330-016-4644-4. Epub 2016 Nov 4.
9
Pathological complete response after neoadjuvant chemotherapy for rectal cancer with synchronous multiple liver metastases: a report of an unusual case.同步多发肝转移直肠癌新辅助化疗后的病理完全缓解:1例罕见病例报告
Surg Case Rep. 2016 Dec;2(1):106. doi: 10.1186/s40792-016-0231-9. Epub 2016 Sep 30.
10
Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.隐匿性转移作为挑战当前结直肠癌肝转移治疗算法的模型。
World J Gastroenterol. 2016 Apr 21;22(15):3937-44. doi: 10.3748/wjg.v22.i15.3937.